(Q34019319)

30 July 2017

title

Eltrombopag does not affect cardiac repolarization: results from a definitive QTc study in healthy subjects (English)

1 reference

30 July 2017

Gemma Matthys

1

1 reference

30 July 2017

Jung Wook Park

2

1 reference

30 July 2017

Sandra McGuire

3

1 reference

30 July 2017

Mary Beth Wire

4

1 reference

30 July 2017

Jianping Zhang

5

1 reference

30 July 2017

Carolyn Bowen

6

1 reference

30 July 2017

Daphne Williams

7

1 reference

30 July 2017

Julian M Jenkins

8

1 reference

30 July 2017

Bin Peng

9

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

British Journal of Clinical Pharmacology

30 July 2017

published in

1 reference

30 July 2017

volume

70

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

24-33

1 reference

Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

Drug-induced prolongation of the QT interval

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

The impact of drug-induced QT interval prolongation on drug discovery and development

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

Ambulatory electrocardiographic recording in endurance athletes

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2909804

Arrhythmias documented by 24-hour continuous ambulatory electrocardiographic monitoring in young women without apparent heart disease

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20642544

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.2010.03646.X

1 reference

30 July 2017

1 reference

30 July 2017

1 reference